Equity
Treasury Stock
Pfizer Treasury Stock increased by 0.2% to $115.19B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.2%, from $115.01B to $115.19B. Over 5 years (FY 2020 to FY 2025), Treasury Stock shows relatively stable performance with a 0.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026
How to read this metric
An increase in treasury stock indicates an active share buyback program, which is often used to return capital to shareholders or offset dilution from employee stock plans.
Detailed definition
This represents the cost of shares that the company has repurchased from the open market and currently holds. These shar...
Peer comparison
Used by investors to evaluate a company's capital return policy and management's view on the valuation of their own stock.
Metric ID:
treasury_stockHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $111.36B | $111.36B | $111.36B | $113.93B | $113.94B | $113.95B | $113.97B | $114.47B | $114.48B | $114.49B | $114.49B | $114.76B | $114.76B | $114.76B | $114.76B | $115.01B | $115.01B | $115.01B | $115.02B | $115.19B |
| QoQ Change | — | +0.0% | +0.0% | +2.3% | +0.0% | +0.0% | +0.0% | +0.4% | +0.0% | +0.0% | +0.0% | +0.2% | +0.0% | +0.0% | +0.0% | +0.2% | +0.0% | +0.0% | +0.0% | +0.2% |
| YoY Change | — | — | — | — | +2.3% | +2.3% | +2.3% | +0.5% | +0.5% | +0.5% | +0.5% | +0.2% | +0.2% | +0.2% | +0.2% | +0.2% | +0.2% | +0.2% | +0.2% | +0.2% |
Range$111.36B – $115.19B
CAGR+0.7%
Avg YoY Growth+0.7%
Median YoY Growth+0.2%
Current Streak19+ quarters growth
Treasury Stock at Other Companies
Frequently Asked Questions
- What is Pfizer's treasury stock?
- Pfizer (PFE) reported treasury stock of $115.19B in Q1 2026.
- How has Pfizer's treasury stock changed year-over-year?
- Pfizer's treasury stock increased by 0.2% year-over-year, from $115.01B to $115.19B.
- What is the long-term trend for Pfizer's treasury stock?
- Over 5 years (2020 to 2025), Pfizer's treasury stock has grown at a 0.7% compound annual growth rate (CAGR), from $110.99B to $115.02B.
- What does treasury stock mean?
- The value of shares the company has bought back from the market.